Detalhe da pesquisa
1.
Detectable Lipidomes and Metabolomes by Different Plasma Exosome Isolation Methods in Healthy Controls and Patients with Advanced Prostate and Lung Cancer.
Int J Mol Sci
; 24(3)2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36768152
2.
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.
Curr Treat Options Oncol
; 23(8): 1104-1120, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716328
3.
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 23(16)2022 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36012272
4.
Racial Disparities in Early-Stage NSCLC Treatment: A Call for Action.
Cancer Epidemiol Biomarkers Prev
; 33(6): 769-770, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587480
5.
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer.
Cancers (Basel)
; 16(5)2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38473302
6.
ctDNA Monitoring for Small Cell Lung Cancer: Ready for Prime Time?
Clin Cancer Res
; 29(12): 2176-2178, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097069
7.
Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data.
Cancers (Basel)
; 15(3)2023 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765587
8.
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349125
9.
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.
Res Sq
; 2023 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36993328
10.
Osimertinib vs. afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an EGFR exon 19 deletion or exon 21 L858R mutation.
J Thorac Dis
; 15(11): 6115-6125, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090314
11.
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.
NPJ Precis Oncol
; 7(1): 100, 2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783809
12.
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(22): 4596-4605, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702716
13.
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
Clin Lung Cancer
; 24(7): e242-e246, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451930
14.
Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent.
J Clin Oncol
; 40(6): 567-575, 2022 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985936
15.
Overcoming KRAS-Mutant Lung Cancer.
Am Soc Clin Oncol Educ Book
; 42: 1-11, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412860
16.
Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress.
Am Soc Clin Oncol Educ Book
; 41: 1-23, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33979196
17.
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors.
Mol Diagn Ther
; 25(6): 757-774, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725800
18.
A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations.
J Thorac Dis
; 13(7): 4054-4062, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34422335
19.
Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA.
Cancers (Basel)
; 13(22)2021 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830765
20.
ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34250420